tirzepatide vs. semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Subcutaneously administered tirzepatide vs semaglutide

Bisphenol A (BPA) and cell signaling pathways

In addition, to best serve survival, energy homoeostasis is directly regulated by overlapping neuronal and hormonal signalling that alters appetite, food craving and foraging behaviour to balance short-term fluctuations in energy intake

Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al

doi: 10.1177/2040622315609312 [DOI] [PMC free article] [PubMed] [Google Scholar] 59

chronic wound microbiota Acute and chronic wounds have fundamentally different healing processes, immunological responses, and underlying causes

doi: 10.1210/clinem/dgz289 50 PaparoSRFerrariSMPatrizioAEliaGRagusaFBotriniCet al